Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy.
Ontology highlight
ABSTRACT: Although immunotherapy represents one of the most potent therapeutic anti-cancer approaches, only a limited number of patients shows clinical benefit. Recent evidence suggests that patients' nutritional status plays a major role in immunotherapy outcome. Fatty acids are essential in a balanced diet and well-known to influence the immune response. Moreover, short-chain fatty acids (SCFAs) show beneficial effects in metabolic disorders as well as in cancer and polyunsaturated fatty acids (PUFAs) contribute to body weight and fat free mass preservation in cancer patients. In line with these data, several studies imply a role for SCFAs and PUFAs in boosting the outcome of immunotherapy. In this review, we specifically focus on mechanistic data showing that SCFAs modulate the immunogenicity of
SUBMITTER: Westheim AJF
PROVIDER: S-EPMC9260274 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA